Efficacy Analysis Demonstrates Covaxin to Be 93.4% Effective Against Severe Symptomatic ... - Latest Tweet by ANI

Efficacy analysis demonstrates Covaxin to be 93.4% effective against severe symptomatic COVID19. Efficacy data demonstrates 65.2% protection against the SARS-CoV-2, B.1.617.2 Delta variant: Bharat Biotech— ANI (@ANI) July 3, 2021

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)